FisherM., MoreD.G.The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intens Care1981; 9: 226–235.
2.
LaxenaireM.C.Adverse reactions to intravenous agents in anaesthesia in France. Commun. Symposium “Histamine and anti-histamine in anaesthesia and surgery”, Munich, 3-5 June 1981.
3.
DundeeJ.W.Hypersensitivity to intravenous anaesthetic agents. Br J Anaesth1976; 48: 57.
4.
WatkinsJ.Anaphylactoid reactions to IV substances. Br J Anaesth1979; 51: 51.
FisherM.Intradermal testing in the diagnosis of acute anaphylaxis during anaesthesia. Results of five years experience. Anaesth Intens Care1979; 7: 58–61.
7.
LorenzW., DoenickeA.Adverse response to intravenous drugs.Acad. Press, London.
8.
GerardH., LegrasB., Moneret-VautrinD.A.Le test de degranulation des basophiles humains (TDBH): leucoconcentration et calcul statistique applique au taux de degranulation. Pathol Biol1981; 29: 137.
9.
JuhlinL., MichaelssonG., ZetterstromO.Urticaria and asthma induced by food and drug additives in patients with aspirin sensitivity. J Allerg Clin Immunol1972; 50: 92.
10.
FreedmanB.J.Asthma induced by sulphur dioxide, benzoate and tartrazine contained in orange drinks. Clin Allergy1977b; 7: 407.
11.
DelaneyJ.C.Asthma, nasal polyposis, and aspirin idiosyncrasy, Lancet1972; ii: 338.
12.
RosenhallL.Hypersensitivity to analgesic, preservatives and food colourants in patients with asthma or rhinitis. Acta Universitatis Upsaliensis1977; 269: 1.
13.
OsterballeO., Taudorfe, HaahrJ.Asthma bronchiale of konservering-smidler, farvestoffer og acetylsalicylsyre hos born. Ugeskr Laeg1979; 141: 1908.
14.
WeberR.W., HoffmanM., RaineD.A.Jr, NelsonH.S.Incidence of bronchoconstriction due to aspirin, asodyes, non-azo-dyes and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol1979; 64: 32.
15.
EngineerD.M., NiederhauserU., PiperP.J., SiroisP.Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine. Br J Pharmacol1978; 62: 61.
16.
SullinvanT.J., ParkerC.W.Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells. J Immunol1979; 122: 431.
17.
MaroneG., Kagey-SobotkaA., LichtensteinL.M.Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. J Immunol1979; 123: 1669.
18.
HolroydeM.C., AltounyanR.E.C., ColeM., ElliottE.V.Bronchoconstriction produced in man by leukotrienes C. and D. Lancet1981; 11: 17.
19.
RegalJ.F., PickeringR.J.C5a-induced tracheal contraction: effect of an SRS-A antagonist and inhibitors or arachidonate metabolism. J Immunol1981; 126: 313.